Table 1.
Schedule and content of PRO surveys.
| Measure | Construct | Baseline | Day 0 | Days 1–6 | Day 7 | Day 14 | Day 21 | Day 30 | Day 60 | Day 90 |
|---|---|---|---|---|---|---|---|---|---|---|
| Demographics survey | Demographics | X | ||||||||
| CCI | Comorbidities | X | ||||||||
| FACT-G | HRQOL | X | X | X | X | X | X | X | X | |
| PROMIS-29 + 2 Profile v2.1 | HRQOL | X | X | X | X | X | X | X | X | |
| FACT-G7 | HRQOL | X | ||||||||
| PRO-CTCAE items | Toxicity burden | X | X | X | X | X | X | X | X | |
| Study-specific survey | Acceptability | X |
Abbreviations: CCI, Charlson Comorbidity Index; FACT-G, Functional Assessment of Cancer Therapy-General; HRQOL, health-related quality of life; PRO-CTCAE, Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events; PROMIS, Patient-Reported Outcomes Measurement Information System.